Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Radiology

What Causes Breast Fibrosis Without Radiation Treatment?

At a Glance

Breast fibrosis can occur without radiation and is usually benign. Common causes include fibrocystic change, healing after surgery or injury, and less commonly diabetes-related or immune-related conditions. Because fibrosis can mimic cancer on scans, biopsy findings must match the imaging.

While radiation is a known cause of scar tissue, breast fibrosis—a condition where the breast develops extra connective tissue—frequently occurs in people who have never had radiation [1]. It is important to know that not every firm area of fibrosis has the same underlying cause [2]. Instead, non-radiation fibrosis is usually a benign (non-cancerous) process, such as a natural fibrocystic change, a healing response from past surgery, or an immune-related condition [3][4][5]. Because fibrotic tissue can feel firm and look suspicious on imaging scans, it can closely mimic breast cancer [1][6]. Understanding these different patterns of fibrosis can help clarify your biopsy results and guide your next steps.

Fibrocystic Changes and Idiopathic Stromal Fibrosis

The most common reasons for fibrous tissue in the breast are benign changes that happen naturally.

  • Fibrocystic change: This is a broad category of benign breast changes that can cause symptoms like pain or palpable lumps [3]. It can include stromal fibrosis (an overgrowth of the breast’s supportive connective or “stromal” tissue), as well as cysts and enlarged milk ducts [3][7].
  • Idiopathic stromal fibrosis: Sometimes, a biopsy shows pure stromal fibrosis without an identifiable underlying cause [2]. “Idiopathic” means that no specific trigger or disease was identified during your evaluation—the biopsy simply describes a benign tissue pattern without establishing why it occurred [2][6].

Healing After Surgery or Trauma

Just like skin forms a scar after a cut, breast tissue forms internal scar tissue as it heals from injury [1]. This type of fibrosis is a normal biological response to prior breast surgeries, such as biopsies, lumpectomies, or breast reduction procedures [4]. This healing process can result in dense scar tissue, architectural distortion, or fat necrosis (a condition where damaged fat cells form firm lumps or calcium deposits) [4][1]. These postoperative changes can create firm areas in the breast that mimic the feel and imaging appearance of a tumor [4].

Immune and Metabolic Conditions

In some cases, breast fibrosis may be associated with systemic (body-wide) health conditions [8].

  • Diabetic mastopathy: This is a rare, benign breast disease (“mastopathy”) that most commonly affects people with long-standing diabetes, particularly Type 1 [9][10]. It causes dense, keloid-like (scar-like) fibrosis and inflammation around the milk-producing glands (lobules) and ducts, often resulting in hard, painless lumps [11][9].
  • Lymphocytic mastopathy: Similar inflammatory fibrosis can sometimes happen in patients without diabetes [8]. It has been reported in association with autoimmune disorders such as Hashimoto’s thyroiditis, lupus, Sjögren syndrome, and Addison disease [8][5].

While these conditions are linked to breast inflammation, having lymphocytic mastopathy does not guarantee that an autoimmune disease is the root cause for an individual person [5]. Most people with benign breast fibrosis do not have an underlying metabolic disorder, and any further testing should be based on your overall health rather than the breast finding alone [5].

How Doctors Diagnose the Cause

Because fibrosis does not have one uniform appearance, your radiologist may recommend a biopsy for suspicious or indeterminate imaging findings [6][12]. Fibrotic tissue can look irregular, cast shadows on an ultrasound, or take up contrast dye (enhance) on an MRI—all of which overlap with the appearance of malignant tumors [1][6]. Because imaging alone cannot definitively tell the difference, a core needle biopsy (which removes small cylinders of tissue for microscopic examination) is used to identify the exact tissue pattern, such as scar tissue, diabetic mastopathy, or fibrocystic change [12][11].

After the biopsy, your radiologist and treating team check for radiologic-pathologic concordance [13]. This means they compare the biopsy results to your imaging scans to verify that the benign tissue adequately explains the suspicious area [13].

  • If the results are concordant (matching): The finding is usually considered reassuring, and your doctor may recommend follow-up imaging (such as a mammogram or MRI at 12 months) to monitor the area [3][2]. You should continue to report any interval changes, such as a mass that enlarges, which may warrant repeat evaluation [2].
  • If the results are discordant (not matching): This may mean the biopsy did not adequately sample the abnormality [13]. In this case, repeat image-guided sampling or surgical excision may be necessary to ensure no cancer is present [13][14].

Common questions in this guide

Can breast fibrosis happen if I have never had radiation?
Yes. Breast fibrosis can result from benign fibrocystic changes, healing after surgery or injury, or an unexplained pattern called idiopathic stromal fibrosis. Less commonly, it is associated with conditions such as diabetic mastopathy or lymphocytic mastopathy.
Does breast fibrosis mean I have breast cancer?
Usually not; most non-radiation breast fibrosis is benign. However, scar-like tissue can feel firm and look irregular on a mammogram, ultrasound, or MRI, so a core needle biopsy may be needed when imaging is suspicious. The biopsy result must be compared with the area seen on imaging.
What health conditions can be linked to breast fibrosis?
Diabetic mastopathy is associated mainly with long-standing diabetes, especially type 1 diabetes. Lymphocytic mastopathy has been reported with autoimmune disorders such as Hashimoto thyroiditis, lupus, Sjögren syndrome, and Addison disease. These associations do not prove that an autoimmune or metabolic condition caused fibrosis in a particular person.
Why might I need a biopsy for breast fibrosis?
Fibrosis can cast shadows on ultrasound or enhance on MRI, which can overlap with the appearance of cancer. A core needle biopsy removes small tissue samples so a pathologist can identify the pattern, such as scar tissue, stromal fibrosis, or diabetic mastopathy. Doctors then compare the biopsy with the imaging findings.
What happens if my biopsy and breast imaging do not match?
If the biopsy adequately explains the imaging finding, your doctor may recommend follow-up imaging, often around 12 months. If the results do not explain the suspicious area, repeat image-guided sampling or surgical removal of the area may be recommended to rule out an unsampled cancer.
Does benign breast fibrosis need another mammogram or MRI?
Follow-up depends on whether the biopsy and imaging findings match and on your individual history. When they match, your doctor may recommend short-term follow-up imaging, such as a mammogram or MRI at about 12 months, before returning to routine screening. Report a growing or changing lump promptly.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my pathology report specify the exact pattern of fibrosis I have, such as idiopathic stromal fibrosis, scar tissue, or diabetic mastopathy?
  2. 2.Are my biopsy results completely concordant (matching) with the suspicious area seen on my imaging scans?
  3. 3.If the results are discordant, what type of repeat sampling or surgical biopsy do you recommend to adequately sample the area?
  4. 4.Do I need short-term follow-up imaging (like a 12-month mammogram or MRI) to monitor this area, or can I return to routine annual screening?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Histopathology and elastography discordance in evaluation of breast lesions with acoustic radiation force impulse elastography.

    Toprak N, Yokus A, Gündüz M, Akdenız H

    Polish journal of radiology 2019; (84()):e224-e233 doi:10.5114/pjr.2019.86852.

    PMID: 31481994
  2. 2

    Stromal Fibrosis of the Breast: A Spectrum of Benign to Malignant Imaging Appearances.

    Nassar L, Baassiri A, Salah F, et al.

    Radiology research and practice 2019; (2019()):5045908 doi:10.1155/2019/5045908.

    PMID: 30886748
  3. 3

    Fibrocystic Changes of the Breast: Radiologic-Pathologic Correlation of MRI.

    Choe AI, Kasales C, Mack J, et al.

    Journal of breast imaging 2022; (4(1)):48-55 doi:10.1093/jbi/wbab071.

    PMID: 38422411
  4. 4

    "Reductive" Reasoning: Identifying Normal Postoperative Changes Versus Malignancy After Reduction Mammoplasty.

    Shamir SB, McNally C, Mathur A, et al.

    Journal of breast imaging 2026; (8(5)):581-593 doi:10.1093/jbi/wbag031.

    PMID: 42544941
  5. 5

    Diabetic mastopathy: A rare clinicopathologic entity with considerable autoimmune potential.

    Boumarah DN, AlSinan AS, AlMaher EM, et al.

    International journal of surgery case reports 2022; (95()):107151 doi:10.1016/j.ijscr.2022.107151.

    PMID: 35576751
  6. 6

    Stromal fibrosis: imaging features with diagnostic contribution of diffusion-weighted MRI.

    Yilmaz R, Bayramoglu Z, Kartal MG, et al.

    The British journal of radiology 2018; (91(1085)):20170706 doi:10.1259/bjr.20170706.

    PMID: 29388800
  7. 7

    An Interesting Imaging Presentation of a Common Benign Entity: Fibrocystic Changes in a Postmenopausal Patient.

    Dang BQ, Miles B, Young P, et al.

    Cureus 2023; (15(3)):e36292 doi:10.7759/cureus.36292.

    PMID: 37073209
  8. 8

    Diabetic Mastopathy: A Systematic Review of Surgical Management of a Rare Breast Disease.

    Agochukwu NB, Wong L

    Annals of plastic surgery 2017; (78(4)):471-475 doi:10.1097/SAP.0000000000000879.

    PMID: 28272124
  9. 9

    Diabetic Fibrous Mastopathy: Imaging Features With Histopathologic Correlation.

    Patel PB, Carter GJ, Berg WA

    Journal of breast imaging 2023; (5(5)):585-590 doi:10.1093/jbi/wbad033.

    PMID: 38416913
  10. 10

    Clinical-radiologic-pathologic characterization of diabetic mastopathy: an analysis of 21 cases.

    Chen J, Zhang C, Liu Z, et al.

    Frontiers in endocrinology 2026; (17()):1691578 doi:10.3389/fendo.2026.1691578.

    PMID: 41648728
  11. 11

    Lymphocyte subsets contribute to the degree of lobulitis and ductitis in sclerosing lymphocytic lobulitis of the breast.

    Chen LY, Tsang JY, Ni YB, et al.

    Journal of clinical pathology 2016; (69(6)):527-32 doi:10.1136/jclinpath-2015-203334.

    PMID: 26582743
  12. 12

    Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis.

    Kim J, Kim EK, Kim MJ, et al.

    Ultrasonography (Seoul, Korea) 2016; (35(2)):140-7 doi:10.14366/usg.15052.

    PMID: 26810194
  13. 13

    Institutional Review of BI-RADS 5 and BI-RADS 4C Lesions Over 5 Years Following Surgical Excision: Analysis of Radiology-Pathology Correlation.

    Brodsky JE, Ly M, Jang S, et al.

    Journal of breast imaging 2026; (8(5)):540-549 doi:10.1093/jbi/wbag019.

    PMID: 42479170
  14. 14

    Correlation of Histopathology and Radiological Findings Among the Diverse Breast Lesions in a Tertiary Care Centre.

    Mohan R, Selvakumar A S, S R, et al.

    Cureus 2024; (16(1)):e52097 doi:10.7759/cureus.52097.

    PMID: 38344545

This page explains possible non-radiation causes of breast fibrosis for informational purposes only and does not constitute medical advice. Your radiologist, pathologist, or breast clinician should interpret your imaging and biopsy results.

Get notified when new evidence is published on breast fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.